Overall Fundamental outlook

Business Operations:

Sector: Healthcare
Industry: Diagnostics & Research

IQVIA Holdings Inc. provides clinical research services, commercial insights, and healthcare intelligence to the life sciences and healthcare industries in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions. The Technology & Analytics Solutions segment offers a range of cloud-based applications and associated implementation services; real world solutions that enable life sciences and provider customers to generate and disseminate evidence, which informs health care decision making and improves patients' outcomes; and strategic and implementation consulting services, such as advanced analytics and commercial processes outsourcing services. This segment also provides country level performance metrics related to sales of pharmaceutical products, prescribing trends, medical treatment, and promotional activity across various channels, including retail, hospital, and mail order; and measurement of sales or prescribing activity at the regional, zip code, and individual prescriber level. The Research & Development Solutions segment offers project management and clinical monitoring; clinical trial support; strategic planning and design services; and patient and site centric solutions, as well as central laboratory, genomic, bioanalytical, ADME, discovery, vaccine and biomarker laboratory services. The Contract Sales & Medical Solutions segment provides health care provider and patient engagement services, and scientific strategy and medical services. It serves pharmaceutical, biotechnology, device and diagnostic, and consumer health companies. The company was formerly known as Quintiles IMS Holdings, Inc. and changed its name to IQVIA Holdings Inc. in November 2017. IQVIA Holdings Inc. is based in Durham, North Carolina.

Revenue projections:

Revenue projections for IQV
Revenue projections for IQV

IQV's revenue projections indicate a decrease from the prior year, which may make investors hesitant. A revenue decline could harm the company's bottom line, prompting investors to be more careful, as lower earnings often signal potential issues with profitability and future performance.

Financial Ratios:

currentRatio 0.749000
forwardPE 11.349116
debtToEquity 245.928000
earningsGrowth 0.236000
revenueGrowth 0.103000
grossMargins 0.332920
operatingMargins 0.151700
trailingEps 7.830000
forwardEps 14.079510

IQVIA Holdings Inc.'s Forward PE being in a good range indicates the stock is priced well relative to its earnings. It is not overvalued, leaving space for future growth, making it an appealing option for investors interested in long-term value appreciation.
IQV's high debt-to-equity ratio indicates significant leverage, meaning the company has more debt compared to its equity. While this can accelerate growth, it also increases financial risk if revenue or profits decline.
IQV's positive earnings and revenue growth suggest that the company is expected to expand its business. This reflects a healthy financial outlook, as IQV's increasing profits and sales signal further growth in the near future.
IQV's forward EPS surpassing its trailing EPS signals projected growth in profitability, with the company expected to perform better this year. This forecast suggests that IQV's earnings will improve compared to the previous financial year, highlighting optimism in its financial outlook.

Price projections:

Price projections for IQV
Price projections for IQV

Over time, IQV's price projections have steadily declined, reflecting reduced confidence in the company's future performance. The downward revisions suggest analysts are becoming more conservative in their assessments.

Insider Transactions:

Insider Transactions for IQV
Insider Transactions for IQV


In recent market activity, 3 sales of IQV shares took place, with market price at 211.5300038655599.The period under consideration did not see any sell transactions.The recent trend of more purchases than sales at IQV's current price could signal investor optimism. This pattern may point to a positive outlook for the stock, as it indicates growing confidence in its potential to perform well in the future.

Recommendation changes over time:

Recommendations trend for IQV
Recommendations trend for IQV


A recent buy bias from analysts toward IQV may inspire confidence in investors, who could view the stock as a promising investment. This positive sentiment suggests that IQV might be an appealing option for those looking to grow their wealth through stock market investments.